Andrew Wiese, PhD, MPH
Andrew Wiese is an Assistant Professor in the Department of Health Policy at the Vanderbilt University School of Medicine. Dr. Wiese is a pharmacoepidemiologist whose research aims to leverage observational studies to provide real-world evidence of the safety and efficacy of commonly used medications and vaccines. His current work is focused on characterizing the safety of medication use for patients and infants during pregnancy and in the postpartum period, assessing the impact of pharmaceutical policies on medication use and medication-related outcomes, and implementing novel research methods to examine drug dose exposures using administrative data.
Dr. Wiese is the PI of a NIH/NIDA funded career development award examining the impact of benzodiazepine restriction policies on benzodiazepine-related harms. Dr. Wiese is a former Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12 Scholar and a former Vanderbilt Faculty Research Scholar. Dr. Wiese completed his postdoctoral training in the Department of Health Policy at the Vanderbilt University School of Medicine and is the former recipient of a PhRMA Foundation Postdoctoral Fellowship in Health Outcomes. Dr. Wiese obtained his MPH from Saint Louis University, his PhD in Epidemiology from Vanderbilt University, and is a former CDC/CSTE Applied Epidemiology Fellow in the Healthcare-Associated Infections Program at the Tennessee Department of Health.